G-CSF levels are elevated in patients with NSCLC relative to healthy individuals (103.2 vs. 24.0 pg/mL, p < 0.001) and higher levels appear to be associated with a poorer prognosis (7). Here, CSF3 is linked to non-small cell lung carcinoma.